Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes

Nephrology Dialysis Transplantation

Volumn 20, Issue , 2005, Pages 1134-1139

  Wu, Chia Chao ^a,b   Chen, Jin Shuen ^b   Wu, Wen Mein ^c   Liao, Tung Nan ^d   Chu, Pauling ^b   Lin, Shih Hua ^b   Chuang, Chien Huei ^b   Lin, Yuh Feng ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

Author keywords

Antioxidants; Biocompatibility; Haemodialysis; Myeloperoxidase; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CELLULOSE; GLUTATHIONE PEROXIDASE; MYELOPEROXIDASE; POLYSULFONE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS MEMBRANE; EQUIPMENT DESIGN; ERYTHROCYTE; FEMALE; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MONOCYTE; NEUTROPHIL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; OXIDATIVE STRESS; PEROXIDASE; RENAL DIALYSIS; SUPEROXIDES;

EID: 20844455941     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh764     Document Type: Article

References (17)

1. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663
2. Descamps-Latscha B, Drüeke T, Witko-Sarsat V. Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy. Semin Dial 2001; 14: 193-199
3. Himmelfarb J, Hakim RM. Oxidative stress in uremia. Curr Opin Nephrol Hypertens 2003; 12: 593-598
4. Babior BM. Phagocytes and oxidative stress. Am J Med 2000; 109: 33-44
5. Samouilidou E, Grapsa E. Effect of dialysis on plasma total antioxidant capacity and lipid peroxidation products in patients with end-stage renal failure. Blood Purif 2003; 21: 209-212
6. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304-1313
7. Tarng DC, Huang TP, Liu TY, Chen HW, Sung YJ, Wei YH. Effect of vitamin E-bonded membrane on the 8-hydroxy 2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int 2000; 58: 790-799
8. Ward RA, McLeish KR. Oxidant stress in hemodialysis patients: what are the determining factors? Artif Organs 2003; 27: 230-236
9. Kosch M, Levers A, Fobker M et al. Dialysis filter type determines the acute effect of haemodialysis on endothelial function and oxidative stress. Nephrol Dial Transplant 2003; 18: 1370-1375
10. Robinson PJ, Carter WO, Narayana PD. Oxidative product formation analysis by flow cytometry. In: Darzynkiewicz Z, Robinson JP, Crissman HA, eds. Methods in Cell Biology, Flow Cytometry, Part A. Academic Press, San Diego: 1994; 437-442
11. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049-6055
12. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169
13. Yagi K. Lipid peroxides and human diseases. Chem Phys Lipids 1987; 45: 337-351
14. Akagi S, Nagake Y, Kasahara J et al. Significance of 8-hydroxy-2′-deoxyguanosine levels in patients with chronic renal failure. Nephrology (Carlton) 2003; 8: 192-195
15. Malle E, Buch T, Grone HJ. Myeloperoxidase in kidney disease. Kidney Int 2003; 64: 1956-1967
16. Gastaldello K, Husson C, Wens R, Vanherweghem JL, Tielemans C. Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis. Nephrol Dial Transplant 2000; 15: 1638-1646
17. Weiss SJ, Lampert MB, Test ST. Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science 1983; 222: 625-628